Holzleitner, Nadine
Fischer, Sebastian
Maniyankerikalam, Isabel
Beck, Roswitha
Lapa, Constantin
Wester, Hans-Jürgen
Günther, Thomas http://orcid.org/0000-0002-7412-0297
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (461577150)
Technische Universität München
Article History
Received: 4 December 2023
Accepted: 26 February 2024
First Online: 2 March 2024
Declarations
:
: Nothing to declare.
: Nothing to declare.
: H.-J.W. is founder and shareholder of Scintomics GmbH, Munich, Germany. A patent application on CCK-2R-targeted compounds with N.H., C.L., H.-J.W., and T.G. as inventors has been filed. No other potential conflicts of interest relevant to this article exist.